Published in Ophthalmology on June 01, 2005
Ocular drug delivery. AAPS J (2010) 2.19
Recent advances in ophthalmic drug delivery. Ther Deliv (2010) 1.31
Use of preclinical models to improve treatment of retinoblastoma. PLoS Med (2005) 1.31
Effect of eye pigmentation on transscleral drug delivery. Invest Ophthalmol Vis Sci (2008) 1.25
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res (2013) 1.06
Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma. Arch Ophthalmol (2009) 1.05
Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death. PLoS Genet (2010) 1.01
Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review. PLoS One (2014) 0.97
AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models. Neuromolecular Med (2009) 0.95
Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol (2012) 0.89
Carboplatin +/- topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. PLoS One (2013) 0.85
Characterization of the biological effect of fish fibrin glue in experiments on rats: immunological and coagulation studies. J Biomed Mater Res A (2010) 0.79
Transgenic Models in Retinoblastoma Research. Ocul Oncol Pathol (2015) 0.78
Comprehensive evaluation of fibrin glue as a local drug-delivery system-efficacy and safety of sustained release of vancomycin by fibrin glue against local methicillin-resistant Staphylococcus aureus infection. J Artif Organs (2013) 0.78
Superimposed fungal ulcer after fibrin glue sealant in infectious corneal ulcer. Korean J Ophthalmol (2011) 0.77
Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy). PLoS One (2016) 0.76
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy. Cancer Nanotechnol (2010) 0.75
Comparing DTL microfiber and Neuroline skin electrode in the Mini Ganzfeld ERG. BMC Ophthalmol (2016) 0.75
Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial. Indian J Ophthalmol (2014) 0.75
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Inadvertent evisceration of eyes containing uveal melanoma. Arch Ophthalmol (2009) 4.25
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Clinicopathologic findings from lacrimal sac biopsy specimens obtained during dacryocystorhinostomy. Ophthal Plast Reconstr Surg (2003) 2.92
Spontaneous corneal clearing after Descemet's stripping without endothelial replacement. Ophthalmology (2011) 2.81
Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol (2002) 2.20
Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol (2012) 2.12
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol (2002) 1.81
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Age-related retinopathy in NRF2-deficient mice. PLoS One (2011) 1.71
Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol (2003) 1.69
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Congenital fibrovascular pupillary membranes: clinical and histopathologic findings. Ophthalmology (2011) 1.67
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. Am J Ophthalmol (2008) 1.60
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol (2010) 1.53
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Mod Pathol (2003) 1.44
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
The future promise and the current reality of genetic prognostication in patients with uveal melanoma. Arch Ophthalmol (2008) 1.40
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Multiple pilomatrixoma in Turner syndrome. Ophthal Plast Reconstr Surg (2009) 1.39
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Clinical outcome of confluent laser photoablation for retinopathy of prematurity. J AAPOS (2002) 1.32
Morphometric changes of the choriocapillaris and the choroidal vasculature in eyes with advanced glaucomatous changes. Vision Res (2002) 1.27
Mucinous eccrine adenocarcinoma of the eyelid: report of 6 cases. Can J Ophthalmol (2010) 1.24
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology (2003) 1.19
Development of a unique small molecule modulator of CXCR4. PLoS One (2012) 1.18
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
p120-Catenin is required for mouse vascular development. Circ Res (2010) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol (2006) 1.12
Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology (2004) 1.11
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Human eyelid meibomian glands and tarsal muscle are recognized by autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in El-Bagre, Colombia, South America. J Am Acad Dermatol (2010) 1.10
Ocular oncology research: the advance of patient care and science. Am J Ophthalmol (2002) 1.10
HER2 targeted molecular MR imaging using a de novo designed protein contrast agent. PLoS One (2011) 1.09
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases. Ophthalmology (2009) 1.08
Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity. J Med Chem (2010) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Ocular argyrosis after long-term self-application of eyelash tint. Am J Ophthalmol (2006) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg (2008) 1.06
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol (2005) 1.06
Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma. Arch Ophthalmol (2009) 1.05
Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retina (2004) 1.05
Enzymatic detergents and toxic anterior segment syndrome. Ophthalmology (2013) 1.05
Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis. Invest Ophthalmol Vis Sci (2009) 1.05
Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest Ophthalmol Vis Sci (2011) 1.05
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci (2007) 1.05
Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest Ophthalmol Vis Sci (2009) 1.05
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Pathology and genetics of primary central nervous system and intraocular lymphoma. Hematol Oncol Clin North Am (2005) 1.04
Masquerade syndromes: malignancies mimicking inflammation in the eye. Int Ophthalmol Clin (2002) 1.03
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg (2007) 1.01
Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Clin Cancer Res (2008) 1.01
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology (2002) 1.00
Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci (2009) 1.00
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00
Neural system antigens are recognized by autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in Colombia. J Clin Immunol (2011) 1.00
Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina (2009) 0.99
Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells. Invest Ophthalmol Vis Sci (2005) 0.99
Barriers to glaucoma drug delivery. J Glaucoma (2008) 0.99
Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells. Invest Ophthalmol Vis Sci (2004) 0.99
Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest Ophthalmol Vis Sci (2008) 0.98
Nocardia veterana endogenous endophthalmitis in a cardiac transplant patient. J Ophthalmic Inflamm Infect (2013) 0.98
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci (2006) 0.98
M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Exp Eye Res (2012) 0.98
Ex vivo confocal microscopy of human LASIK corneas with histologic and ultrastructural correlation. Ophthalmology (2005) 0.98
Frontiers in the management of retinoblastoma. Am J Ophthalmol (2009) 0.97
Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp Mol Pathol (2011) 0.97
Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol (2002) 0.96